We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UHAL icon
651
U-Haul Holding Co
UHAL
$14.3B
$775K 0.01%
20,860
+9,530
+84% +$346K
CTRA
652
DELISTED
Coterra Energy
CTRA
$759K 0.01%
29,094
-3,096
-10% -$77.6K
HSIC icon
653
Henry Schein
HSIC
$9.64B
$754K 0.01%
12,543
+911
+8% +$55K
GIB icon
654
CGI
GIB
$14.5B
$747K 0.01%
10,856
+4,754
+78% +$314K
ACGN
655
DELISTED
Aceragen Inc
ACGN
$740K 0.01%
17,076
– –
SHG icon
656
Shinhan Financial Group
SHG
$33.6B
$739K 0.01%
19,879
– –
CPB icon
657
Campbell Soup
CPB
$6.67B
$736K 0.01%
19,299
-38,905
-67% -$1.37M
FLR icon
658
Fluor
FLR
$7.22B
$732K 0.01%
19,893
-108
-0.5% -$3.95K
WUBA
659
DELISTED
58.com Inc
WUBA
$723K 0.01%
11,000
-124,000
-92% -$7.81M
KDNY
660
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$720K 0.01%
+36,200
New +$631K
OC icon
661
Owens Corning
OC
$11.6B
$702K 0.01%
14,902
– –
DXCM icon
662
DexCom
DXCM
$28.3B
$686K 0.01%
23,052
+3,100
+16% +$109K
CBOE icon
663
Cboe Global Markets
CBOE
$30.2B
$679K 0.01%
7,113
– –
VOD icon
664
Vodafone
VOD
$36.4B
$673K 0.01%
37
– –
TPR icon
665
Tapestry
TPR
$29.8B
$672K 0.01%
20,673
+3,111
+18% +$109K
BVN icon
666
Compañía de Minas Buenaventura
BVN
$8.06B
$662K 0.01%
+38,287
New +$625K
LSXMK
667
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$658K 0.01%
22,595
– –
HWM icon
668
Howmet Aerospace
HWM
$115B
$654K 0.01%
44,595
+635
+1% +$9.1K
KB icon
669
KB Financial Group
KB
$41.5B
$639K 0.01%
17,248
– –
QVCGA
670
DELISTED
QVC Group Inc Series A
QVCGA
$614K 0.01%
791
– –
CX icon
671
Cemex
CX
$17.6B
$613K 0.01%
132,125
-11,280
-8% -$56.4K
BMS
672
DELISTED
Bemis
BMS
$610K 0.01%
11,000
– –
ALB icon
673
Albemarle
ALB
$13.7B
$608K 0.01%
7,419
– –
WHR icon
674
Whirlpool
WHR
$2.44B
$606K 0.01%
4,563
– –
RDHL
675
Redhill Biopharma
RDHL
$4.26M
$592K 0.01%
71
– –
25 26
27
28 29

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.